Comments
Loading...

Elanco Animal Health Analyst Ratings

ELANNYSE
Logo brought to you by Benzinga Data
$9.15
-0.57-5.86%
At close: -
$9.15
0.000.00%
After Hours: Apr 4, 4:00 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$20.00
Lowest Price Target1
$9.00
Consensus Price Target1
$15.45

Elanco Animal Health Analyst Ratings and Price Targets | NYSE:ELAN | Benzinga

Elanco Animal Health Inc has a consensus price target of $15.45 based on the ratings of 11 analysts. The high is $20 issued by Morgan Stanley on November 15, 2022. The low is $9 issued by Goldman Sachs on April 25, 2023. The 3 most-recent analyst ratings were released by Piper Sandler, UBS, and Morgan Stanley on March 6, 2025, February 26, 2025, and February 26, 2025, respectively. With an average price target of $14 between Piper Sandler, UBS, and Morgan Stanley, there's an implied 53.01% upside for Elanco Animal Health Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
1
Dec 24
1
1
Jan
4
1
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.4
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Piper Sandler
UBS
Morgan Stanley
Stifel
Barclays

1calculated from analyst ratings

Analyst Ratings for Elanco Animal Health

Buy NowGet Alert
03/06/2025Buy Now31.15%Piper Sandler
David Westenberg59%
$16 → $12MaintainsNeutralGet Alert
02/26/2025Buy Now85.79%UBS
Andrea Alfonso12%
$18 → $17MaintainsBuyGet Alert
02/26/2025Buy Now42.08%Morgan Stanley
Erin Wright76%
$14 → $13MaintainsEqual-WeightGet Alert
02/26/2025Buy Now63.93%Stifel
Jonathan Block71%
$16 → $15MaintainsBuyGet Alert
02/26/2025Buy Now107.65%Barclays
Balaji Prasad53%
$20 → $19MaintainsOverweightGet Alert
02/21/2025Buy Now74.86%Stifel
Jonathan Block71%
$18 → $16MaintainsBuyGet Alert
01/29/2025Buy Now53.01%Morgan Stanley
Erin Wright76%
$15 → $14MaintainsEqual-WeightGet Alert
01/07/2025Buy Now96.72%Stifel
Jonathan Block71%
$20 → $18MaintainsBuyGet Alert
12/09/2024Buy Now96.72%UBS
Andrea Alfonso12%
→ $18Initiates → BuyGet Alert
12/02/2024Buy Now53.01%Leerink Partners
Daniel Clark15%
→ $14Initiates → Market PerformGet Alert
11/08/2024Buy Now118.58%Barclays
Balaji Prasad53%
$19 → $20MaintainsOverweightGet Alert
10/28/2024Buy Now107.65%Barclays
Balaji Prasad53%
$22 → $19MaintainsOverweightGet Alert
09/23/2024Buy Now140.44%Barclays
Balaji Prasad53%
$21 → $22MaintainsOverweightGet Alert
09/19/2024Buy Now118.58%Stifel
Jonathan Block71%
$20 → $20ReiteratesBuy → BuyGet Alert
09/19/2024Buy Now63.93%Morgan Stanley
Erin Wright76%
$17 → $15DowngradeOverweight → Equal-WeightGet Alert
07/01/2024Buy Now74.86%Piper Sandler
David Westenberg59%
$19 → $16MaintainsNeutralGet Alert
06/28/2024Buy Now129.51%Barclays
Balaji Prasad53%
$23 → $21MaintainsOverweightGet Alert
05/13/2024Buy Now107.65%Piper Sandler
David Westenberg59%
$18 → $19ReiteratesNeutral → NeutralGet Alert
05/09/2024Buy Now151.37%Barclays
Balaji Prasad53%
$19 → $23MaintainsOverweightGet Alert
03/12/2024Buy Now96.72%Piper Sandler
David Westenberg59%
$12 → $18ReiteratesNeutral → NeutralGet Alert
02/27/2024Buy Now53.01%Goldman Sachs
Nathan Rich43%
$12.5 → $14MaintainsSellGet Alert
02/27/2024Buy Now85.79%Morgan Stanley
Erin Wright76%
$16 → $17MaintainsOverweightGet Alert
02/27/2024Buy Now107.65%Barclays
Balaji Prasad53%
$18 → $19MaintainsOverweightGet Alert
01/17/2024Buy Now36.61%Goldman Sachs
Nathan Rich43%
$10 → $12.5MaintainsSellGet Alert
01/05/2024Buy Now118.58%Stifel
Jonathan Block71%
$13 → $20UpgradeHold → BuyGet Alert
12/19/2023Buy Now85.79%Jefferies
Glen Santangelo50%
→ $17Initiates → BuyGet Alert
12/15/2023Buy Now74.86%Morgan Stanley
Erin Wright76%
→ $16UpgradeEqual-Weight → OverweightGet Alert
12/07/2023Buy Now42.08%Stifel
Jonathan Block71%
$12 → $13MaintainsHoldGet Alert
11/13/2023Buy Now31.15%Piper Sandler
David Westenberg59%
$11 → $12MaintainsNeutralGet Alert
11/08/2023Buy Now74.86%Morgan Stanley
Erin Wright76%
$17 → $16MaintainsEqual-WeightGet Alert
10/30/2023Buy Now31.15%Stifel
Jonathan Block71%
$13 → $12MaintainsHoldGet Alert
08/14/2023Buy Now42.08%Piper Sandler
David Westenberg59%
$9 → $13MaintainsNeutralGet Alert
08/09/2023Buy Now3.83%Goldman Sachs
Nathan Rich43%
$8.5 → $9.5MaintainsSellGet Alert
08/08/2023Buy Now3.83%Goldman Sachs
Nathan Rich43%
$8.5 → $9.5MaintainsSellGet Alert
04/26/2023Buy Now-1.64%Goldman Sachs
Nathan Rich43%
$10.5 → $9MaintainsSellGet Alert
04/25/2023Buy Now-1.64%Goldman Sachs
Nathan Rice60%
$10.5 → $9MaintainsSellGet Alert
04/20/2023Buy Now53.01%Barclays
Balaji Prasad53%
→ $14UpgradeEqual-Weight → OverweightGet Alert
02/22/2023Buy Now53.01%Barclays
Balaji Prasad53%
$18 → $14MaintainsEqual-WeightGet Alert
01/30/2023Buy Now107.65%Morgan Stanley
Erin Wright76%
$20 → $19MaintainsEqual-WeightGet Alert
11/15/2022Buy Now118.58%Morgan Stanley
Joseph Moore69%
$21 → $20MaintainsEqual-WeightGet Alert
11/14/2022Buy Now63.93%Piper Sandler
David Westenberg59%
$21 → $15MaintainsNeutralGet Alert
11/09/2022Buy Now31.15%Goldman Sachs
Nathan Rich43%
$19 → $12MaintainsSellGet Alert
10/17/2022Buy Now118.58%JP Morgan
Chris Schott60%
$24 → $20MaintainsNeutralGet Alert
10/07/2022Buy Now129.51%Morgan Stanley
Joseph Moore69%
$22 → $21MaintainsEqual-WeightGet Alert
09/12/2022Buy Now96.72%Barclays
Balaji Prasad53%
$32 → $18MaintainsEqual-WeightGet Alert
08/18/2022Buy Now140.44%Morgan Stanley
Erin Wright76%
$37 → $22DowngradeOverweight → Equal-WeightGet Alert
08/17/2022Buy Now129.51%Piper Sandler
David Westenberg59%
$22 → $21MaintainsNeutralGet Alert
08/16/2022Buy NowJP Morgan
Chris Schott60%
DowngradeOverweight → NeutralGet Alert
07/21/2022Buy Now107.65%Goldman Sachs
Nathan Rich43%
$32 → $19DowngradeBuy → SellGet Alert
07/18/2022Buy Now249.73%JP Morgan
Chris Schott60%
$37 → $32MaintainsOverweightGet Alert
07/12/2022Buy Now140.44%Piper Sandler
David Westenberg59%
→ $22Initiates → NeutralGet Alert
06/24/2022Buy Now140.44%Stifel
Jonathan Block71%
$30 → $22MaintainsHoldGet Alert
05/19/2022Buy Now249.73%Goldman Sachs
Nathan Rich43%
$37 → $32MaintainsBuyGet Alert
05/17/2022Buy Now304.37%Morgan Stanley
Erin Wright76%
$40 → $37MaintainsOverweightGet Alert

FAQ

Q

What is the target price for Elanco Animal Health (ELAN) stock?

A

The latest price target for Elanco Animal Health (NYSE:ELAN) was reported by Piper Sandler on March 6, 2025. The analyst firm set a price target for $12.00 expecting ELAN to rise to within 12 months (a possible 31.15% upside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Elanco Animal Health (ELAN)?

A

The latest analyst rating for Elanco Animal Health (NYSE:ELAN) was provided by Piper Sandler, and Elanco Animal Health maintained their neutral rating.

Q

When was the last upgrade for Elanco Animal Health (ELAN)?

A

The last upgrade for Elanco Animal Health Inc happened on January 5, 2024 when Stifel raised their price target to $20. Stifel previously had a hold for Elanco Animal Health Inc.

Q

When was the last downgrade for Elanco Animal Health (ELAN)?

A

The last downgrade for Elanco Animal Health Inc happened on September 19, 2024 when Morgan Stanley changed their price target from $17 to $15 for Elanco Animal Health Inc.

Q

When is the next analyst rating going to be posted or updated for Elanco Animal Health (ELAN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Elanco Animal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Elanco Animal Health was filed on March 6, 2025 so you should expect the next rating to be made available sometime around March 6, 2026.

Q

Is the Analyst Rating Elanco Animal Health (ELAN) correct?

A

While ratings are subjective and will change, the latest Elanco Animal Health (ELAN) rating was a maintained with a price target of $16.00 to $12.00. The current price Elanco Animal Health (ELAN) is trading at is $9.15, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch